Document
IPR2016-00649, No. 2081 Exhibit - Prescription Drug Trends, Kaiser Family Foundation, Fact Sheet No 3057 30, Oct 2004 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2081 Exhibit - Prescription Drug Trends, Kaiser Family Foundation, Fact Sheet No 3057 30, Oct 2004 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2021 Exhibit - SICOR Pharmaceuticals ANDA Suitability Petition Methotrexate Injection, USP 100mb mL, dated April 28, 2006 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2021 Exhibit - SICOR Pharmaceuticals ANDA Suitability Petition Methotrexate Injection, USP 100mb mL, dated April 28, 2006 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2040 Exhibit - Greenapple, R, Trends in Biologic Therapies for Rheumatoid Arthritis Results from a Survey of Payers and Providers, American Health and Drug Benefits 201...
Cite Document
IPR2016-00649, No. 2040 Exhibit - Greenapple, R, Trends in Biologic Therapies for Rheumatoid Arthritis Results from a Survey of Payers and Providers, American Health and Drug Benefits 2012 (P.T.A.B.
+ More Snippets
Document
IPR2016-00649, No. 2014 Exhibit - Breslin, et al, Improving Tolerance and Bioavailability of Methotrexate by Switching from Oral to Subcutaneous Route of Administration, Rheumatology 388 20...
Cite Document
IPR2016-00649, No. 2014 Exhibit - Breslin, et al, Improving Tolerance and Bioavailability of Methotrexate by Switching from Oral to Subcutaneous Route of Administration, Rheumatology 388 2005 (P.T.A.B
+ More Snippets
Document
IPR2016-00649, No. 2057 Exhibit - October 2014 ASP Pricing File 09 12 14, Centers for Medicare and Medicaid Services (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2057 Exhibit - October 2014 ASP Pricing File 09 12 14, Centers for Medicare and Medicaid Services (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2073 Exhibit - Guidance for Industry Applications Covered by Section 505b2,US Food and Drug Administration, Oct 1999 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2073 Exhibit - Guidance for Industry Applications Covered by Section 505b2,US Food and Drug Administration, Oct 1999 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2045 Exhibit - Michaud, K et al, Direct Medical Costs and Their Predictors in Patients with Rheumatoid Arthritis, Arthritis and Rheumatism 2003 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2045 Exhibit - Michaud, K et al, Direct Medical Costs and Their Predictors in Patients with Rheumatoid Arthritis, Arthritis and Rheumatism 2003 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2017 Exhibit - Antares Pharma Press Release, Antares Pharma Announces the Publication of a Head to Head, Randomized, Crossover Study of Oral versus Subcutaneous ...
Cite Document
IPR2016-00649, No. 2017 Exhibit - Antares Pharma Press Release, Antares Pharma Announces the Publication of a Head to Head, Randomized, Crossover Study of Oral versus Subcutaneous Methotrexate in Pati
+ More Snippets
Document
IPR2016-00649, No. 2012 Exhibit - Bingham SJ et al Parenteral methotrexate should be given before biological therapy, Rheumatology 2003 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2012 Exhibit - Bingham SJ et al Parenteral methotrexate should be given before biological therapy, Rheumatology 2003 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2063 Exhibit - Antares Thoughts on the Upcoming Otrexup TM Launch, Seeking Alpha 2013 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2063 Exhibit - Antares Thoughts on the Upcoming Otrexup TM Launch, Seeking Alpha 2013 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2009 Exhibit - Andrea T Borchers et al, The Use of Methotrexate in Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism Aug 2004 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2009 Exhibit - Andrea T Borchers et al, The Use of Methotrexate in Rheumatoid Arthritis, Seminars in Arthritis and Rheumatism Aug 2004 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2034 Exhibit - Ashburn, T et al, Drug Repositioning Identifying and Developing New Uses for Existing Drugs, Nature Reviews Drug Discovery 2004 (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2034 Exhibit - Ashburn, T et al, Drug Repositioning Identifying and Developing New Uses for Existing Drugs, Nature Reviews Drug Discovery 2004 (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2058 Exhibit - Declaration of Brian Gummow (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2058 Exhibit - Declaration of Brian Gummow (P.T.A.B. Jun. 2, 2016)
+ More Snippets
Document
IPR2016-00649, No. 2049 Exhibit - Saag, K et al, American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease Modifying Antirheumatic Drugs in R...
Cite Document
IPR2016-00649, No. 2049 Exhibit - Saag, K et al, American College of Rheumatology 2008 Recommendations for the Use of Nonbiologic and Biologic Disease Modifying Antirheumatic Drugs in Rheumatoid Arthr
+ More Snippets
Document
IPR2016-00649, No. 2078 Exhibit - Juvenile Idiopathic Arthritis JIA, NYU Langone Medical Center Division of Pediatric Rheumatology (P.T.A.B. Jun. 2, 2016)
Cite Document
IPR2016-00649, No. 2078 Exhibit - Juvenile Idiopathic Arthritis JIA, NYU Langone Medical Center Division of Pediatric Rheumatology (P.T.A.B. Jun. 2, 2016)
+ More Snippets